The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.
James Talarico’s adoptive father linked to X account mocking Christianity and women
Fauci Diary Entry Complains Trump Pushed Lab-Leak Theory ‘With No Evidence’
Cyberattack Turns Hundreds of Grocery Coolers Into Saunas – Dozens of US Military Stores Faced Similar, Unexplained Attack
Trump tries different approach with Russia to bring Americans relief amid ongoing war with Ukraine
House panel warns Singham-linked nonprofits: Comply with subpoenas or face Congress
Lawsuit Accuses McDonald’s of AI Scheme to Nickel-And-Dime Customers ‘Down to the Last French Fry’
Even NBC Admits It: Trump Rallies Are Galvanizing Voters, Could Impact Midterms in Battleground States
Talarico’s Texas-sized opening: Paxton can’t unite Republican vote
Mamdani praised over move to dismantle controversial NYC industry — but insiders say there’s more to the story
Becoming a lawyer could get cheaper and faster under looming Trump admin shakeup
Michigan Democrat confirms sister-in-law’s terror watchlist lawsuit days before Obama campaign appearance
Top takeaways from JD Vance town hall: Costly gas, DC corruption, immigration hot takes and the war
‘No Kings’ protesters spurn organizers’ rules: ‘This is as partisan as you can get’
Minnesota Senate race takes bizarre turn after dark family history uncovered
Bend school district honors slain teacher, praises staff member’s courage during attack: ‘Forever grateful’
HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”
Earlier, the French government had approved similar drugs to treat the virus.
Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”
James Talarico’s adoptive father linked to X account mocking Christianity and women
Fauci Diary Entry Complains Trump Pushed Lab-Leak Theory ‘With No Evidence’
Cyberattack Turns Hundreds of Grocery Coolers Into Saunas – Dozens of US Military Stores Faced Similar, Unexplained Attack
Trump tries different approach with Russia to bring Americans relief amid ongoing war with Ukraine
House panel warns Singham-linked nonprofits: Comply with subpoenas or face Congress
Lawsuit Accuses McDonald’s of AI Scheme to Nickel-And-Dime Customers ‘Down to the Last French Fry’
Even NBC Admits It: Trump Rallies Are Galvanizing Voters, Could Impact Midterms in Battleground States
Talarico’s Texas-sized opening: Paxton can’t unite Republican vote
Mamdani praised over move to dismantle controversial NYC industry — but insiders say there’s more to the story
Becoming a lawyer could get cheaper and faster under looming Trump admin shakeup
Michigan Democrat confirms sister-in-law’s terror watchlist lawsuit days before Obama campaign appearance
Top takeaways from JD Vance town hall: Costly gas, DC corruption, immigration hot takes and the war
‘No Kings’ protesters spurn organizers’ rules: ‘This is as partisan as you can get’
Minnesota Senate race takes bizarre turn after dark family history uncovered
Bend school district honors slain teacher, praises staff member’s courage during attack: ‘Forever grateful’
President Donald Trump has suggested that hydroxychloroquine could be effective, and has encouraged further study. His interest in the drug has prompted pushback from the media.
NBC News’ Peter Alexander accused the president last week of giving Americans “false hope,” and Politico’s Dan Diamond reported Sunday that the FDA decision came despite “scant evidence,” adding that “[c]areer scientists have been skeptical of the effort.”
Story cited here.
